| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000016531 |
| Receipt No. | R000019145 |
| Official scientific title of the study | A safety and efficacy exploratory study of daikenchuto to relieve abdominal bloating in patients who has been ileostomy. |
| Date of disclosure of the study information | 2015/02/13 |
| Last modified on | 2018/08/17 (Ver. 6) |
| Basic information | ||
| Official scientific title of the study | A safety and efficacy exploratory study of daikenchuto to relieve abdominal bloating in patients who has been ileostomy. | |
| Title of the study (Brief title) | A safety and efficacy exploratory study of daikenchuto to relieve abdominal bloating in patients who has been ileostomy. | |
| Region |
|
|
| Condition | |||
| Condition | Ileostomy patients with abdominal bloating | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | The purpose of this study is to determine whether daikenchuto is effective and safe in the treatment of abdominal bloating who has been ileostomy. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | 1)Abdominal bloating
2)Gastrointestinal symptom rating scale(GSRS) 3)Analysis of ileostomy effluent -intestinal flora -organic acid -pH |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Taking Daokenchuto 15g/day orally for 4 weeks. | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1)Patients who has been ileostomy
2)Patients with abdominal bloating 3)Age: more than or equal to 20 years at the time of providing informed consent 4)Patients are male or female 5)Patients are in patients or out patients 6)Patients have ileotoma. 7)Provide written informed consent |
|||
| Key exclusion criteria | 1)Patients with strangulating intestinal obstruction.
2)Patients who are administrated preparation for viable organism within 4 weeks before this study. 3)Patients who was administrated daikenchuto or any Japanese traditional herbal medicine within 4 weeks before this study 4)Virus-positive (HIV, HBV, HCN) 5)Patients have serious coexisting disease (ex. Hepatic distorder, kidney disorder, cardiac disorder, hematological disorder, or metabolic disorder) 6)Women who was lactating or pregnant or person who hope the pregnancy of the partne. 7)Unsuitability as determined by the study doctor |
|||
| Target sample size | 10 | |||
| Research contact person | |
| Name of lead principal investigator | Toru Kono |
| Organization | Sapporo Higashi Tokushukai Hospital |
| Division name | Center for Clinical and Biomedical Research |
| Address | 3-1, Kita 33-jo Higashi 14-chome, Higashi-ku, Sapporo |
| TEL | 011-722-1110 |
| kono@toru-kono.com | |
| Public contact | |
| Name of contact person | Toru Kono |
| Organization | Sapporo Higashi Tokushukai Hospital |
| Division name | Center for Clinical and Biomedical Research |
| Address | 3-1, Kita 33-jo Higashi 14-chome, Higashi-ku, Sapporo |
| TEL | 011-722-1110 |
| Homepage URL | |
| kono@toru-kono.com | |
| Sponsor | |
| Institute | Sapporo Higashi Tokushukai Hospital Center for Clinical and Biomedical Research |
| Institute | |
| Department | |
| Funding Source | |
| Organization | TSUMURA & CO. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000019145 |